Innovate UK & PPR
Financially backed. Technically ahead.
Out of 661 applications, Innovate UK selected 24 · 89.3% score
We ranked 1st
Not because of a number. Because we proposed a solution to a systemic problem in health tech, one that goes far beyond any single system, and made the case that we could actually solve it.
70% grant funded , four-component ML framework, validated via four-arm ablation study against predefined clinical targets
UK patent filed (GB2506289.4, April 2025) for the PPR algorithm; no blocking prior art identified to date
This access alone is rare. Fewer than 30 health tech companies in the UK hold the clinical system integration WACure has; only a handful of providers are integrated with the NHS App at all, and WACure is on track to be among the next.
The market this points to is not small. Globally comparable AI-assessment platforms, Ada Health, K Health, Infermedica, Doctolib, have been valued between hundreds of millions and several billion dollars. WACure holds a position few UK competitors can currently match: live NHS integration, a funded, patent-pending algorithm, and a platform already generating revenue, not a research project looking for its first customer.
What comes next
This is only the beginning of the funded roadmap.
Phase 1 takes PPR from early-stage research to a validated prototype. Subsequent phases, subject to government approval and Phase 1 results, would take it further: from prototype to a production-grade system in live clinical use, and eventually to full commercial scale.
Each phase is structured to follow directly from the one before it, the same programme, the same algorithm, progressively de-risked with public funding at every stage before private capital is asked to carry it further.
What's Behind It
What PPR is, and why it's defensible
Personalised Posterior Refinement (PPR) is the move from a rule-based Online Consultation to an ML/AI-native one, an EHR-conditioned engine that reads a patient's history and adapts in real time, instead of running the same fixed script for everyone.
This isn't a feature. It's a structural advantage.
It took over a year to build, and would take a competitor at least that long to replicate.
- Regulatory moat — DTAC, DCB0129, NHS DSPT, Cyber Essentials Plus, ICB assurance, and both major clinical system integrations (EMIS and SystmOne IM1). This certification set typically takes 24+ months. WACure holds it after 12.
- Algorithmic moat — PPR is built on Sequential Bayesian Experimental Design, positioned as the core algorithmic novelty in our Innovate UK Frontier AI application. UK patent application filed.
- Data moat — every live consultation adds to a growing set of question-answer-outcome calibration data. Competitors running static decision trees don't improve with use. This does.
- Switching cost moat — once a practice's EMIS or SystmOne integration is live, its entire patient communication infrastructure runs through WACure. Migrating out is disruptive in a way migrating in isn't.
- Partner moat — WhatsApp Approved Tech Partner status. Meta grants this to very few healthcare companies globally; competitors would need 12–18 months of dedicated investment to reach the same status.
What We're Working Towards
A future where no consultation starts blind, anywhere in the world.
Today, an online consultation asks every patient the same questions, in the same order, regardless of who they are or what their record already knows about them. We believe that's a temporary limitation, not a permanent feature of digital healthcare, anywhere in the world.
Our goal is a consultation that thinks the way a clinician does: reading the patient's history before it asks a single question, adapting in real time to what it learns, and knowing when it has enough information to stop.
We're starting inside NHS primary care, because it's where the need is most acute and the evidence bar is highest, but the problem we're solving isn't a British one. Every health system in the world asks patients the same static questions, wastes clinical time on information a record already holds, and treats each consultation as if it were the patient's first. That's not a policy failure. It's a missing layer of intelligence, and it's the same layer wherever you build it.
We're building it openly and rigorously: every stage of PPR is validated against real clinical scenarios, reviewed against evidence, and designed so a clinician can see exactly why the system reached the priority it did. Nothing is a black box, and nothing replaces clinical judgement, it exists to sharpen it.
Proven in the NHS, one of the most rigorous and demanding health systems in the world, this approach is designed to travel. What we validate here becomes the foundation for how personalised, evidence-led consultation works everywhere.
That's the direction we're building towards: a future where no patient answers a question their record could already answer, no clinician starts a consultation blind, anywhere in the world.